GlassScriptPhysician profile
Corey Jason Steinberg
NPI 1497174734
$614.57
in general payments reported to CMS, 2019-2025
15 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $39.59 · 2024: $328 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.68 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $104.06 | 2024-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $78.10 | 2023-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $45.40 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Boston Scientific Corporation | $44.88 | 2025 | Watchman Access System |
| Exact Sciences Corporation | $42.38 | 2024-2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $39.68 | 2024 | Inspire |
| Alnylam Pharmaceuticals INC. | $37.22 | 2024-2025 | Givlaari |
| Lilly USA, LLC | $36.65 | 2024-2025 | Zepbound, Mounjaro |
| Coastal Medical Technologies LLC | $34.28 | 2025 | |
| Pfizer INC. | $31.97 | 2024 | |
| Dynavax Technologies Corporation | $27.91 | 2025 | Heplisav-B |
| Abbvie INC. | $27.44 | 2024 | |
| Merck Sharp & Dohme LLC | $23.23 | 2025 | Capvaxive, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $20.87 | 2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $20.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.